CLIB General Assembly 2026
This year’s CLIB General Assembly took place at CLIB member Bayer AG in Bergkamen on 03 November 2026 and was opened by Chairman Roland Breves (Biotech Consult Breves). Dennis Herzberg, CLIB’s Cluster Manager, presented the cluster’s direction and the strategic pillars. Building on the outcomes of the most recent closed-door meeting, the network’s strategy was further refined. The focus is particularly on market access, regulatory matters, scale-up and the commercialisation of biotechnological innovations. CLIB remains a biotechnology cluster with a strong core in North Rhine-Westphalia, embedded within a high-performing European network and with international appeal.
The cluster’s central claims, #NetworkingBiotechnology and #CreatingSustainability, remain unchanged. CLIB continues to interpret the concept of sustainability in a holistic sense and explicitly includes resilience and competitiveness as essential prerequisites for a successful transformation.
At the General Assembly, the Executive Board was discharged and will remain in office as scheduled. In addition, Lars Börger (nova-Institut) and Tilman Breitenstein (Scalable IP) were elected as the new auditors. CLIB would like to extend its sincere thanks to the outgoing auditors, Timo Koch (Pfeifer & Langen) and Oliver Bonkamp (BioSecurity), for their commitment and valuable work over the past few years.
During the General Assembly, project managers from the CLIB team presented the projects and activities of the past year and also provided an outlook on the planned priorities and initiatives for 2027.
We would like to thank all members who attended the annual general meeting and look forward to further networking within and around the cluster.


